InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Fairmount Funds Management Llc, Director, is a corporate insider tracked by InsiderTape across 6 companies. The public record shows 10 open-market SEC Form 4 transactions: 7 purchases worth $115.9M and 3 sales worth $769.7M, reported from Jun 16, 22 to Jul 16, 26. Over this period they have been a net buyer.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 16, 26 | CBIOCRESCENT BIOPHARMA, INC. | BUY | 853.5K | $14.50 | $12.4M |
| Jun 23, 26 | SYRESpyre Therapeutics, Inc. | SELL | 4.68M | $85.31 | $399.7M |
| May 11, 26 | VRDNViridian Therapeutics, Inc.\DE | BUY | 1.18M | $17.00 | $20.0M |
| Mar 31, 26 | COGTCogent Biosciences, Inc. | SELL | 7.00M | $34.66 | $242.6M |
| Jan 22, 26 | COGTCogent Biosciences, Inc. | SELL | 3.50M | $36.40 | $127.4M |
| Jul 10, 25 | COGTCogent Biosciences, Inc. | BUY | 2.78M | $9.00 | $25.0M |
| Sep 16, 24 | ZBIOZenas BioPharma, Inc. | BUY | 300.0K | $17.00 | $5.1M |
| Jul 13, 23 | APGEApogee Therapeutics, Inc. | BUY | 1.99M | $17.00 | $33.9M |
| Jun 9, 23 | COGTCogent Biosciences, Inc. | BUY | 800.0K | $12.00 | $9.6M |
| Jun 16, 22 | COGTCogent Biosciences, Inc. | BUY | 1.20M | $8.25 | $9.9M |